VitaNova Life Sciences (VNOV) Other Non Operating Income (2024 - 2025)

VitaNova Life Sciences (VNOV) reported Other Non Operating Income of $120.0 for Q4 2025, down 60.0% on a YoY basis from $300.0 in Q4 2024, and down 38.78% quarter-over-quarter from $196.0 in Q1 2025.

VitaNova Life Sciences (VNOV) Other Non Operating Income (2024 - 2025) Analysis & Trends

VitaNova Life Sciences has reported Other Non Operating Income for 2 years, with the latest figure at $120.0 in Q4 2025.

  • For the quarter ending Q4 2025, Other Non Operating Income fell 60.0% year-over-year to $120.0; the trailing twelve-month figure through Jan 2026 stood at $316.0 (down 47.42% YoY), and the FY2025 full-year result was $496.0, up 372.38% from the prior year.
  • Other Non Operating Income for Q4 2025 stood at $120.0, down from $196.0 in the prior quarter.
  • The five-year high for Other Non Operating Income was $300.0 in Q4 2024, with the low at $105.0 in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Akso Health 2,315,158.81 Bn 2,315,158.63 Bn -
2 Mckesson 92.76 Bn 89.18 Bn 4.04 Bn
3 Cencora 52.82 Bn 50.83 Bn 3.59 Bn
4 Cardinal Health 52.17 Bn 48.39 Bn 2.50 Bn
5 Henry Schein 9.19 Bn 9.71 Bn 1.07 Bn
6 Accendra Health 246.88 Mn -90.00 Mn 312.39 Mn
7 Edap Tms 161.92 Mn 146.92 Mn 8.15 Mn
8 111 107.47 Mn 25.61 Mn 23.58 Mn
9 Cosmos Health 9.42 Mn 7.26 Mn 1.38 Mn
10 VitaNova Life Sciences - - 316,343.00

Historic Data

Download Data
DateValue
Oct 31, 2025 120.00
Jan 31, 2025 196.00
Oct 31, 2024 300.00
Apr 30, 2024 105.00